Brill–Zinsser disease

From WikiMD's WELLNESSPEDIA

(Redirected from Brill-Zinsser disease)


Brill–Zinsser disease
Synonyms Recrudescent typhus
Pronounce N/A
Specialty N/A
Symptoms Fever, rash, headache, myalgia
Complications Pneumonia, myocarditis, encephalitis
Onset Years after initial infection
Duration Variable
Types N/A
Causes Reactivation of Rickettsia prowazekii
Risks Previous infection with epidemic typhus
Diagnosis Serology, PCR
Differential diagnosis Epidemic typhus, murine typhus, Rocky Mountain spotted fever
Prevention Vaccination, hygiene
Treatment Doxycycline, chloramphenicol
Medication N/A
Prognosis Generally good with treatment
Frequency Rare
Deaths N/A


Brill–Zinsser disease is a late relapse of the epidemic typhus infection, caused by the bacterium Rickettsia prowazekii. The disease was first described by the American physician Nathan Brill and the German bacteriologist Hans Zinsser in the early 20th century.

Etiology[edit]

Brill–Zinsser disease is caused by the reactivation of Rickettsia prowazekii, the bacterium responsible for epidemic typhus. The bacterium can remain dormant in the body for many years before reactivating and causing disease.

Symptoms[edit]

The symptoms of Brill–Zinsser disease are similar to those of epidemic typhus, but are usually less severe. They include fever, headache, rash, and muscle pain. In severe cases, complications such as pneumonia, myocarditis, and central nervous system involvement may occur.

Diagnosis[edit]

Diagnosis of Brill–Zinsser disease is based on clinical symptoms and a history of epidemic typhus. Laboratory tests, including serology and PCR, can be used to confirm the diagnosis.

Treatment[edit]

Treatment for Brill–Zinsser disease involves antibiotics, usually doxycycline or chloramphenicol. With prompt and appropriate treatment, the prognosis is generally good.

Epidemiology[edit]

Brill–Zinsser disease is rare and occurs sporadically, often many years after the initial epidemic typhus infection. It has been reported in various parts of the world, including Europe, Africa, and the Americas.

Prevention[edit]

Prevention of Brill–Zinsser disease involves control of body lice, which are the main vectors of Rickettsia prowazekii. Vaccination against epidemic typhus may also provide some protection against Brill–Zinsser disease.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.